We are live on ! Find out more
MAM

Marquette Asset Management Portfolio holdings

AUM $779M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
-6.91%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.51%
5 Year Est. Return
+57.16%
10 Year Est. Return
+244.82%
AUM
$430M
AUM Growth
-$46.6M
Cap. Flow
-$11.4M
Cap. Flow %
-2.65%
Top 10 Hldgs %
64.63%
Holding
403
New
139
Increased
77
Reduced
26
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 1.8%
2 Consumer Discretionary 1.34%
3 Healthcare 1.23%
4 Financials 1.09%
5 Industrials 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
151
McDonald's
MCD
$195B
$98K 0.02%
395
+4
+1% +$996
SVVC
152
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$98K 0.02%
+28,326
New +$105K
IRON icon
153
Disc Medicine
IRON
$2.97B
$92K 0.02%
+2,209
New +$116K
STT icon
154
State Street
STT
$50.7B
$92K 0.02%
1,053
+6
+0.6% +$556
TCRR
155
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$92K 0.02%
33,262
+13,283
+66% +$41.8K
JKHY icon
156
Jack Henry & Associates
JKHY
$11.1B
$91K 0.02%
462
IVV icon
157
iShares Core S&P 500 ETF
IVV
$902B
$88K 0.02%
195
-5
-3% -$2.24K
GRC icon
158
Gorman-Rupp
GRC
$2.21B
$87K 0.02%
2,418
ADVM
159
DELISTED
Adverum Biotechnologies
ADVM
$86K 0.02%
6,575
+1,175
+22% +$17.2K
COST icon
160
Costco
COST
$420B
$86K 0.02%
150
SPSB icon
161
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.7B
$84K 0.02%
2,776
SPRB
162
Spruce Biosciences
SPRB
$129M
$82K 0.02%
545
TCRX icon
163
TScan Therapeutics
TCRX
$52M
$81K 0.02%
28,895
+7,277
+34% +$31.5K
AVEM icon
164
Avantis Emerging Markets Equity ETF
AVEM
$26.3B
$80K 0.02%
1,353
DBTX
165
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$78K 0.02%
25,704
+7,232
+39% +$27.7K
IBN icon
166
ICICI Bank
IBN
$108B
$74K 0.02%
3,913
JJSF icon
167
J&J Snack Foods
JJSF
$1.71B
$71K 0.02%
457
UHS icon
168
Universal Health Services
UHS
$10.5B
$71K 0.02%
488
HTLF
169
DELISTED
Heartland Financial USA, Inc.
HTLF
$71K 0.02%
1,479
CAT icon
170
Caterpillar
CAT
$387B
$68K 0.02%
303
+3
+1% +$629
LII icon
171
Lennox International
LII
$15.2B
$67K 0.02%
259
AMAT icon
172
Applied Materials
AMAT
$428B
$66K 0.02%
501
-994
-66% -$137K
HSIC icon
173
Henry Schein
HSIC
$9.82B
$66K 0.02%
756
AFL icon
174
Aflac
AFL
$63.4B
$65K 0.02%
1,010
+10
+1% +$626
TERN
175
DELISTED
Terns Pharmaceuticals
TERN
$65K 0.02%
21,802
+5,183
+31% +$22.1K

Similar funds

Marquette Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Marquette Asset Management held 403 positions worth $430M, down 9.8% from $477M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Marquette Asset Management's Q1 2022 filing shows 139 new, 77 increased, 26 reduced and 11 closed positions. Its largest new stake was Target: 1,454 shares worth $309K. The largest sale was Vanguard Intermediate-Term Bond ETF, an estimated $17.2M.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.7% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marquette Asset Management's largest Q1 2022 buy was Target: 1,454 shares worth $309K.
  • Marquette Asset Management added most to Vanguard Short-Term Bond ETF in Q1 2022, an estimated $10.6M increase.
  • Marquette Asset Management's biggest Q1 2022 reduction was Vanguard Intermediate-Term Bond ETF, cutting an estimated $17.2M.
  • Marquette Asset Management fully exited TAT Technologies in Q1 2022, selling an estimated $366K.
  • Marquette Asset Management's ten largest holdings make up 65% of its $430M portfolio in Q1 2022.
  • Marquette Asset Management opened 139 new positions and closed 11 in Q1 2022.
  • Marquette Asset Management's portfolio value fell 9.8% quarter-over-quarter to $430M.

Based on Marquette Asset Management's 13F filing for Q1 2022, filed 26 Apr 2022.